These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9284369)
1. Recombination in HIV: an important viral evolutionary strategy. Burke DS Emerg Infect Dis; 1997; 3(3):253-9. PubMed ID: 9284369 [TBL] [Abstract][Full Text] [Related]
2. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination. Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Blackard JT; Cohen DE; Mayer KH Clin Infect Dis; 2002 Apr; 34(8):1108-14. PubMed ID: 11915000 [TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
5. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
6. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination. Taylor JE; Korber BT Infect Genet Evol; 2005 Jan; 5(1):85-95. PubMed ID: 15567142 [TBL] [Abstract][Full Text] [Related]
8. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1. Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643 [TBL] [Abstract][Full Text] [Related]
9. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1. Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection. Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166 [TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients. Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333 [TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants. Quan Y; Liang C; Brenner BG; Wainberg MA J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098 [TBL] [Abstract][Full Text] [Related]
13. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471 [TBL] [Abstract][Full Text] [Related]
14. Drug induced superinfection in HIV and the evolution of drug resistance. Leontiev VV; Maury WJ; Hadany L Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234 [TBL] [Abstract][Full Text] [Related]
15. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Chang LJ; Liu X; He J Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613 [TBL] [Abstract][Full Text] [Related]
16. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. Dudley DM; Gao Y; Nelson KN; Henry KR; Nankya I; Gibson RM; Arts EJ Biotechniques; 2009 May; 46(6):458-67. PubMed ID: 19480640 [TBL] [Abstract][Full Text] [Related]
17. Evidence for positive epistasis in HIV-1. Bonhoeffer S; Chappey C; Parkin NT; Whitcomb JM; Petropoulos CJ Science; 2004 Nov; 306(5701):1547-50. PubMed ID: 15567861 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J Virology; 1999 Sep; 262(2):312-20. PubMed ID: 10502510 [TBL] [Abstract][Full Text] [Related]
19. [The biological characterization of HIV-1 isolated in patients with a rapid clinical evolution]. Lobaina Barthelemy L; Dubed Echevarría M; Vilarrubia Montes de Oca OL; Navea Leyva L; Díaz Torres HM; Izquierdo Márquez M; Noa Romero E Rev Cubana Med Trop; 1998; 50(2):96-9. PubMed ID: 10349425 [TBL] [Abstract][Full Text] [Related]
20. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]